Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio
Bayer in Basel is seeking a Senior HEOR Manager for COAs and PROs to lead strategic COA plans across therapeutic areas, guiding trials and contributing to regulatory submissions.You will collaborate with internal teams and external vendors, ensure
At Bayer we’re visionaries, driven to solve the world’s toughest challenges and striving for a world where ,Health for all, Hunger for none’ is no longer a dream, but a real possibility. We’re doing it with
Bayer is seeking a Senior HEOR Manager for Patient-Reported Outcomes on a 12-month contract in Basel. You will lead COA strategy, guide trial planning, and manage external vendors to ensure regulatory-ready COA data across programs.The role demands
Revolution Medicines in Switzerland seeks a Senior Director, Epidemiology, Europe to lead regional epidemiology strategy and evidence generation across the product lifecycle.You will partner with Clinical Development, Global Patient Safety, Medical Affairs, Regulatory, RWE/HEOR, and Market Access
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is seeking a Senior Director of Economic Modeling to lead the strategy and execution of health economic models across its portfolio. You will work with Global HEOR & RWE to support HTA submissions and payer
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company Description Sobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come